hu.MAP 3.0: Complex View
Human Protein Complex Map
Search for a protein
Complex: huMAP3_13851.1
Confidence: Medium
Proteins| Genename | Protein Name | Uniprot Annotation Score | Links |
|---|---|---|---|
| IFNA1 | Interferon alpha-1/13 (IFN-alpha-1/13) (Interferon alpha-D) (LeIF D) | 5 | UniProt NCBI |
| IFNA17 | Interferon alpha-17 (IFN-alpha-17) (Interferon alpha-88) (Interferon alpha-I') (LeIF I) (Interferon alpha-T) | 5 | UniProt NCBI |
| IFNA7 | Interferon alpha-7 (IFN-alpha-7) (Interferon alpha-J) (LeIF J) (Interferon alpha-J1) (IFN-alpha-J1) | 5 | UniProt NCBI |
| KDF1 | Keratinocyte differentiation factor 1 | 5 | UniProt NCBI |
| IFNA6 | Interferon alpha-6 (IFN-alpha-6) (Interferon alpha-54) (Interferon alpha-K) (LeIF K) | 5 | UniProt NCBI |
| IFNA5 | Interferon alpha-5 (IFN-alpha-5) (Interferon alpha-61) (Interferon alpha-G) (LeIF G) | 5 | UniProt NCBI |
| IFNA14 | Interferon alpha-14 (IFN-alpha-14) (Interferon alpha-H) (LeIF H) (Interferon lambda-2-H) | 5 | UniProt NCBI |
| TRIM21 | E3 ubiquitin-protein ligase TRIM21 (EC 2.3.2.27) (52 kDa Ro protein) (52 kDa ribonucleoprotein autoantigen Ro/SS-A) (RING finger protein 81) (Ro(SS-A)) (Sjoegren syndrome type A antigen) (SS-A) (Tripartite motif-containing protein 21) | 5 | UniProt NCBI |
| ISG15 | Ubiquitin-like protein ISG15 (Interferon-induced 15 kDa protein) (Interferon-induced 17 kDa protein) (IP17) (Ubiquitin cross-reactive protein) (hUCRP) | 5 | UniProt NCBI |
| IFNA2 | Interferon alpha-2 (IFN-alpha-2) (Interferon alpha-A) (LeIF A) | 5 | UniProt NCBI |
| IFNA16 | Interferon alpha-16 (IFN-alpha-16) (Interferon alpha-WA) | 4 | UniProt NCBI |
| IFNA8 | Interferon alpha-8 (IFN-alpha-8) (Interferon alpha-B) (LeIF B) (Interferon alpha-B2) | 5 | UniProt NCBI |
| UBA7 | Ubiquitin-like modifier-activating enzyme 7 (Ubiquitin-activating enzyme 7) (EC 6.2.1.-) (D8) (Ubiquitin-activating enzyme E1 homolog) | 5 | UniProt NCBI |
| IFNA4 | Interferon alpha-4 (IFN-alpha-4) (Interferon alpha-4B) (Interferon alpha-76) (Interferon alpha-M1) | 5 | UniProt NCBI |
| UBR3 | E3 ubiquitin-protein ligase UBR3 (EC 2.3.2.27) (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650) | 5 | UniProt NCBI |
Enrichments
| Term ID | Corrected Pval | Fraction Complex Coverage | Proteins | Term Name |
|---|---|---|---|---|
| REAC:R-HSA-168928 | 3.05105001865e-21 | 0.785714285714 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | DDX58/IFIH1-mediated induction of interferon-alpha/beta |
| REAC:R-HSA-912694 | 5.47150116521e-21 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Regulation of IFNA/IFNB signaling |
| GO:0005132 | 1.36636521819e-20 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | type I interferon receptor binding |
| WP:WP4912 | 3.96608105662e-20 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | SARS coronavirus and innate immunity |
| GO:0033141 | 5.80347292239e-20 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| REAC:R-HSA-933541 | 6.69315523409e-20 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | TRAF6 mediated IRF7 activation |
| KEGG:04622 | 8.04795463015e-20 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | RIG-I-like receptor signaling pathway |
| GO:0033139 | 1.10231995308e-19 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | regulation of peptidyl-serine phosphorylation of STAT protein |
| REAC:R-HSA-913531 | 1.48568457162e-19 | 0.857142857143 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | Interferon Signaling |
| WP:WP4655 | 1.68650611014e-19 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | Cytosolic DNA sensing pathway |
| WP:WP4558 | 1.95429002455e-19 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Overview of interferons mediated signaling pathway |
| GO:0042501 | 2.00360024651e-19 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | serine phosphorylation of STAT protein |
| REAC:R-HSA-909733 | 2.04960070687e-19 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | Interferon alpha/beta signaling |
| KEGG:05320 | 3.60600285535e-19 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Autoimmune thyroid disease |
| GO:0002323 | 1.55780303856e-18 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | natural killer cell activation involved in immune response |
| GO:0060337 | 6.12354683739e-17 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | type I interferon-mediated signaling pathway |
| GO:0071357 | 7.2351112125e-17 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | cellular response to type I interferon |
| GO:0043330 | 8.38390420531e-17 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | response to exogenous dsRNA |
| KEGG:04623 | 8.49723407162e-17 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Cytosolic DNA-sensing pathway |
| REAC:R-HSA-9705671 | 1.26999539667e-16 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | SARS-CoV-2 activates/modulates innate and adaptive immune responses |
| GO:0034340 | 1.60133890639e-16 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | response to type I interferon |
| GO:0043331 | 2.51316800351e-16 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | response to dsRNA |
| KEGG:04620 | 6.66657653573e-16 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Toll-like receptor signaling pathway |
| WP:WP75 | 8.96369830738e-16 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Toll like receptor signaling pathway |
| WP:WP5095 | 1.00362354682e-15 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Overview of proinflammatory and profibrotic mediators |
| GO:0140888 | 1.25839056604e-15 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | interferon-mediated signaling pathway |
| KEGG:05169 | 3.33198965926e-15 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | Epstein-Barr virus infection |
| KEGG:04650 | 5.50369824408e-15 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Natural killer cell mediated cytotoxicity |
| GO:0098586 | 7.50346055131e-15 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | cellular response to virus |
| GO:0042100 | 8.93753147402e-15 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | B cell proliferation |
| KEGG:05171 | 1.07974283194e-14 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | Coronavirus disease - COVID-19 |
| KEGG:05162 | 1.82322069572e-14 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Measles |
| KEGG:04936 | 1.82322069572e-14 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Alcoholic liver disease |
| REAC:R-HSA-9705683 | 2.62305915288e-14 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | SARS-CoV-2-host interactions |
| KEGG:04630 | 3.03106491448e-14 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | JAK-STAT signaling pathway |
| KEGG:05160 | 3.03106491448e-14 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Hepatitis C |
| GO:0030101 | 3.24099819128e-14 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | natural killer cell activation |
| WP:WP4630 | 3.54447998374e-14 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Measles virus infection |
| KEGG:04217 | 4.58446765153e-14 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Necroptosis |
| KEGG:05164 | 7.25945887454e-14 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Influenza A |
| GO:0033138 | 7.63901343039e-14 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | positive regulation of peptidyl-serine phosphorylation |
| KEGG:05152 | 8.24319974847e-14 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Tuberculosis |
| KEGG:04621 | 8.24319974847e-14 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | NOD-like receptor signaling pathway |
| GO:0046425 | 8.74519755907e-14 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | regulation of receptor signaling pathway via JAK-STAT |
| KEGG:05161 | 9.34353350113e-14 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Hepatitis B |
| WP:WP4666 | 9.60707789912e-14 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Hepatitis B infection |
| GO:1904892 | 1.4730003079e-13 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | regulation of receptor signaling pathway via STAT |
| GO:0002286 | 1.6703492232e-13 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | T cell activation involved in immune response |
| KEGG:05167 | 2.9942437829e-13 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Kaposi sarcoma-associated herpesvirus infection |
| GO:0030183 | 3.42951379497e-13 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | B cell differentiation |
| KEGG:05165 | 4.83376839164e-13 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | Human papillomavirus infection |
| KEGG:05417 | 5.63311628407e-13 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Lipid and atherosclerosis |
| REAC:R-HSA-1280215 | 5.84251172406e-13 | 0.857142857143 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | Cytokine Signaling in Immune system |
| REAC:R-HSA-983231 | 8.12210109331e-13 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Factors involved in megakaryocyte development and platelet production |
| GO:0033135 | 8.24465140444e-13 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | regulation of peptidyl-serine phosphorylation |
| KEGG:05163 | 1.01621251478e-12 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Human cytomegalovirus infection |
| KEGG:05170 | 1.06558657009e-12 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Human immunodeficiency virus 1 infection |
| REAC:R-HSA-9694516 | 1.15573236144e-12 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | SARS-CoV-2 Infection |
| KEGG:04060 | 1.2850559038e-12 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Cytokine-cytokine receptor interaction |
| GO:0009615 | 1.74483756047e-12 | 0.785714285714 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | response to virus |
| GO:0007259 | 7.51063578716e-12 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | receptor signaling pathway via JAK-STAT |
| GO:0097696 | 1.03471755892e-11 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | receptor signaling pathway via STAT |
| GO:0002285 | 1.20938609708e-11 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | lymphocyte activation involved in immune response |
| REAC:R-HSA-9679506 | 2.89578337764e-11 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | SARS-CoV Infections |
| GO:0005125 | 2.9234047843e-11 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | cytokine activity |
| GO:0045087 | 3.11682694058e-11 | 0.857142857143 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | innate immune response |
| KEGG:04151 | 3.79540681822e-11 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | PI3K-Akt signaling pathway |
| WP:WP4172 | 4.88585926661e-11 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | PI3K Akt signaling pathway |
| REAC:R-HSA-168249 | 5.38309155837e-11 | 0.857142857143 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | Innate Immune System |
| GO:0042113 | 6.12026334254e-11 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | B cell activation |
| GO:0046651 | 1.07363730831e-10 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | lymphocyte proliferation |
| GO:0032943 | 1.28502973539e-10 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | mononuclear cell proliferation |
| GO:0002366 | 1.72029558407e-10 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | leukocyte activation involved in immune response |
| GO:0005126 | 2.15798199509e-10 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | cytokine receptor binding |
| GO:0002263 | 2.15798199509e-10 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | cell activation involved in immune response |
| GO:0006959 | 2.54841278864e-10 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | humoral immune response |
| GO:0140546 | 2.6367629372e-10 | 0.857142857143 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | defense response to symbiont |
| GO:0018105 | 2.84235603596e-10 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | peptidyl-serine phosphorylation |
| GO:0070661 | 3.16601091643e-10 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | leukocyte proliferation |
| KEGG:05168 | 3.59082604079e-10 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Herpes simplex virus 1 infection |
| GO:0018209 | 5.06417153938e-10 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | peptidyl-serine modification |
| GO:0098542 | 6.57213155583e-10 | 0.857142857143 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | defense response to other organism |
| GO:0034097 | 8.18430160229e-10 | 0.785714285714 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | response to cytokine |
| GO:0019221 | 1.39042869211e-09 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | cytokine-mediated signaling pathway |
| GO:0002250 | 1.51898091155e-09 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | adaptive immune response |
| KEGG:05200 | 2.06082663688e-09 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Pathways in cancer |
| GO:0043207 | 5.14398098556e-09 | 0.857142857143 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | response to external biotic stimulus |
| GO:0051707 | 5.14398098556e-09 | 0.857142857143 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | response to other organism |
| GO:0030098 | 5.7561390039e-09 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | lymphocyte differentiation |
| GO:0009607 | 7.60441291357e-09 | 0.857142857143 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | response to biotic stimulus |
| REAC:R-HSA-9824446 | 1.47027565663e-08 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | Viral Infection Pathways |
| GO:1903131 | 1.65385836963e-08 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | mononuclear cell differentiation |
| GO:0048018 | 1.96010266893e-08 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | receptor ligand activity |
| GO:0071345 | 2.06912489534e-08 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | cellular response to cytokine stimulus |
| GO:0030546 | 2.24025913908e-08 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | signaling receptor activator activity |
| GO:0044419 | 2.46262035586e-08 | 0.857142857143 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | biological process involved in interspecies interaction between organisms |
| GO:0030545 | 4.37802581701e-08 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | signaling receptor regulator activity |
| REAC:R-HSA-109582 | 4.45924311371e-08 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Hemostasis |
| GO:0006952 | 4.78466342577e-08 | 0.857142857143 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | defense response |
| GO:0006955 | 5.69855789126e-08 | 0.857142857143 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | immune response |
| GO:0042110 | 7.70466091498e-08 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | T cell activation |
| REAC:R-HSA-168256 | 1.10444526547e-07 | 0.857142857143 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | Immune System |
| REAC:R-HSA-5663205 | 1.12186034528e-07 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | Infectious disease |
| GO:0002521 | 1.75734040364e-07 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | leukocyte differentiation |
| GO:0014070 | 2.16240325311e-07 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | response to organic cyclic compound |
| GO:0002252 | 2.64812524329e-07 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | immune effector process |
| TF:M08500 | 2.77342308517e-07 | 0.357142857143 | IFNA17 IFNA8 IFNA4 IFNA2 IFNA7 | Factor: HOXB2:ETV7; motif: TAATGRNSMGGAARYRCTTCCGS |
| TF:M03575 | 3.30803970462e-07 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Factor: HEN2; motif: CATYTGNNN |
| GO:0031399 | 4.42244890717e-07 | 0.785714285714 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | regulation of protein modification process |
| GO:0001934 | 6.68395314207e-07 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | positive regulation of protein phosphorylation |
| GO:0042327 | 1.05957191423e-06 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | positive regulation of phosphorylation |
| GO:0046649 | 1.70929053238e-06 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | lymphocyte activation |
| GO:0010562 | 3.25244375414e-06 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | positive regulation of phosphorus metabolic process |
| GO:0045937 | 3.25244375414e-06 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | positive regulation of phosphate metabolic process |
| GO:0009605 | 4.53071015601e-06 | 0.857142857143 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | response to external stimulus |
| GO:0036211 | 5.27022512673e-06 | 0.928571428571 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 UBR3 IFNA16 | protein modification process |
| GO:0002376 | 5.34689229034e-06 | 0.857142857143 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | immune system process |
| GO:0030097 | 5.81745563905e-06 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | hemopoiesis |
| GO:1901698 | 8.49227287048e-06 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | response to nitrogen compound |
| GO:0045321 | 1.01989649528e-05 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | leukocyte activation |
| GO:0031401 | 1.10702737221e-05 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | positive regulation of protein modification process |
| GO:0018193 | 1.36513536734e-05 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | peptidyl-amino acid modification |
| GO:0043412 | 1.51975233863e-05 | 0.928571428571 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 UBR3 IFNA16 | macromolecule modification |
| REAC:R-HSA-1643685 | 2.18434220285e-05 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | Disease |
| GO:0001932 | 3.23645380408e-05 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | regulation of protein phosphorylation |
| GO:0001775 | 4.17885054206e-05 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | cell activation |
| GO:0042325 | 5.96705585009e-05 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | regulation of phosphorylation |
| GO:0005102 | 6.21295609098e-05 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | signaling receptor binding |
| TF:M12625_1 | 7.09198784724e-05 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Factor: HOXD1; motif: NATYCAKCAN; match class: 1 |
| GO:0010033 | 7.70854602527e-05 | 0.785714285714 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | response to organic substance |
| TF:M11571_1 | 8.04851788643e-05 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | Factor: HNF-3alpha; motif: YTRWGTMAATATTTRCWYWN; match class: 1 |
| GO:0140677 | 9.66922774075e-05 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | molecular function activator activity |
| TF:M04238 | 0.000152693676178 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | Factor: FOXD2; motif: NRNWAATATTTAYN |
| TF:M00672_1 | 0.000172752452266 | 0.714285714286 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 UBA7 IFNA17 IFNA8 IFNA5 IFNA16 | Factor: TEF; motif: ATGTTWAYATAA; match class: 1 |
| GO:0008283 | 0.00019594293808 | 0.714285714286 | IFNA4 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA8 KDF1 IFNA2 IFNA16 | cell population proliferation |
| GO:0071310 | 0.000201260039956 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | cellular response to organic substance |
| GO:0051246 | 0.000202746893867 | 0.785714285714 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | regulation of protein metabolic process |
| GO:0019220 | 0.000252239302211 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | regulation of phosphate metabolic process |
| GO:0051174 | 0.000255112883234 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | regulation of phosphorus metabolic process |
| GO:0070887 | 0.000269609289406 | 0.785714285714 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | cellular response to chemical stimulus |
| TF:M04383_1 | 0.000306873199217 | 0.785714285714 | IFNA4 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 TRIM21 IFNA8 UBR3 IFNA16 | Factor: LBX2; motif: CTNRANSTAATTA; match class: 1 |
| GO:0044877 | 0.00034720797582 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | protein-containing complex binding |
| GO:0006468 | 0.000753098791533 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | protein phosphorylation |
| TF:M11570_1 | 0.00101767028815 | 0.5 | IFNA14 IFNA16 IFNA5 IFNA6 IFNA17 IFNA7 IFNA8 | Factor: HNF-3alpha; motif: CNYTAAGTAAACAAAN; match class: 1 |
| GO:0051247 | 0.00104967480325 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | positive regulation of protein metabolic process |
| GO:0016310 | 0.00161250165638 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | phosphorylation |
| GO:0006950 | 0.0018156601811 | 0.857142857143 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | response to stress |
| GO:0042221 | 0.00365756066129 | 0.785714285714 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | response to chemical |
| GO:0019538 | 0.00373006000244 | 0.928571428571 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 UBR3 IFNA16 | protein metabolic process |
| TF:M04695 | 0.00389124702766 | 0.571428571429 | IFNA4 IFNA16 IFNA2 IFNA6 IFNA17 IFNA8 IFNA7 IFNA5 | Factor: REST; motif: TTCAGCACCAYGGA |
| GO:0009966 | 0.00500606418465 | 0.785714285714 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | regulation of signal transduction |
| TF:M03788 | 0.00628599850399 | 0.571428571429 | ISG15 IFNA14 IFNA16 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 | Factor: CAR_RXR; motif: CYNNNNTGAMCTYW |
| TF:M10651 | 0.00641099323628 | 0.642857142857 | ISG15 IFNA14 IFNA16 IFNA5 UBA7 IFNA17 IFNA4 IFNA7 IFNA8 | Factor: HOX11L2; motif: YAATTGNNNNNNNNNCAATTN |
| TF:M09952 | 0.00656410999811 | 0.5 | IFNA4 IFNA14 IFNA16 IFNA5 IFNA17 TRIM21 IFNA7 | Factor: hoxa9; motif: NTGATTTATKR |
| TF:M08671 | 0.0122385338435 | 0.857142857143 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 KDF1 IFNA8 IFNA16 TRIM21 | Factor: AP-4:Dlx-3; motif: NCAGCTGNNNNNNGTAATKR |
| GO:0023051 | 0.0133462609484 | 0.785714285714 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | regulation of signaling |
| GO:0031325 | 0.0134087230743 | 0.785714285714 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | positive regulation of cellular metabolic process |
| GO:0010646 | 0.0135344369302 | 0.785714285714 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | regulation of cell communication |
| TF:M00192_1 | 0.014771173946 | 0.642857142857 | ISG15 IFNA14 IFNA7 IFNA5 IFNA4 IFNA17 TRIM21 IFNA8 IFNA16 | Factor: GR; motif: NNNNNNCNNTNTGTNCTNN; match class: 1 |
| GO:0007166 | 0.0154656996807 | 0.714285714286 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 IFNA16 | cell surface receptor signaling pathway |
| TF:M08395 | 0.0174628816399 | 0.5 | IFNA4 IFNA14 IFNA16 IFNA5 IFNA17 TRIM21 IFNA7 | Factor: PBX4:HOXA10; motif: NCATAAATCA |
| TF:M08836 | 0.0197862597318 | 0.785714285714 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 IFNA2 UBR3 IFNA16 | Factor: OCT-2; motif: ATGMATATGCWAAT |
| TF:M04082_1 | 0.0229103483675 | 0.571428571429 | IFNA4 IFNA14 IFNA16 IFNA5 IFNA6 IFNA17 IFNA7 IFNA8 | Factor: POU3F3; motif: WTNAATAWKNAW; match class: 1 |
| TF:M01127 | 0.0259064825775 | 0.357142857143 | IFNA17 IFNA16 IFNA4 IFNA5 IFNA7 | Factor: islet1; motif: GSNTAATRK |
| TF:M07278_1 | 0.0281257662509 | 0.428571428571 | IFNA4 IFNA14 IFNA16 IFNA6 IFNA17 IFNA7 | Factor: Dlx-3; motif: NTAATTNVN; match class: 1 |
| TF:M01420_1 | 0.0289930963429 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA8 TRIM21 IFNA2 | Factor: Ncx; motif: NAATNAATTAATAANWW; match class: 1 |
| GO:0098772 | 0.0307078708864 | 0.642857142857 | IFNA4 IFNA14 IFNA7 IFNA2 IFNA6 IFNA17 IFNA8 IFNA5 IFNA16 | molecular function regulator activity |
| WP:WP619 | 0.0343857858398 | 0.142857142857 | ISG15 IFNA2 | Type II interferon signaling |
| TF:M00802_1 | 0.036386051744 | 0.5 | IFNA4 IFNA14 IFNA16 IFNA8 IFNA17 IFNA7 IFNA2 | Factor: Pit-1; motif: NMTTCATAAWTATWNMNA; match class: 1 |
| GO:0032501 | 0.0366729131395 | 0.928571428571 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 KDF1 IFNA2 UBR3 IFNA16 TRIM21 | multicellular organismal process |
| GO:0048856 | 0.0399952515379 | 0.857142857143 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 KDF1 IFNA2 UBR3 IFNA16 | anatomical structure development |
| GO:0009893 | 0.0469189164211 | 0.785714285714 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 IFNA16 | positive regulation of metabolic process |
| GO:1901564 | 0.047765639209 | 0.928571428571 | ISG15 IFNA14 IFNA7 IFNA5 IFNA6 UBA7 IFNA17 IFNA4 IFNA8 TRIM21 IFNA2 UBR3 IFNA16 | organonitrogen compound metabolic process |
Edges
| Protein 1 | Protein 2 | Score | ProteomeHD |
|---|---|---|---|
| IFNA5 | IFNA16 | 0.999 | |
| IFNA8 | UBR3 | 0.998 | |
| IFNA5 | IFNA14 | 0.998 | |
| IFNA14 | IFNA1 | 0.996 | |
| IFNA7 | IFNA4 | 0.995 | |
| ISG15 | IFNA14 | 0.995 | |
| ISG15 | IFNA1 | 0.994 | |
| IFNA6 | IFNA1 | 0.993 | |
| IFNA5 | IFNA2 | 0.993 | |
| ISG15 | UBA7 | 0.993 | 0.134 |
| IFNA8 | IFNA4 | 0.993 | |
| IFNA2 | IFNA4 | 0.992 | |
| ISG15 | IFNA4 | 0.992 | |
| IFNA5 | IFNA6 | 0.992 | |
| IFNA5 | IFNA17 | 0.989 | |
| IFNA5 | IFNA4 | 0.989 | |
| IFNA2 | ISG15 | 0.989 | |
| IFNA7 | IFNA16 | 0.989 | |
| TRIM21 | IFNA14 | 0.988 | |
| IFNA7 | ISG15 | 0.987 | |
| IFNA6 | ISG15 | 0.986 | |
| IFNA5 | UBR3 | 0.986 | |
| ISG15 | IFNA16 | 0.982 | |
| IFNA1 | IFNA4 | 0.981 | |
| IFNA5 | ISG15 | 0.979 | |
| IFNA7 | UBR3 | 0.978 | |
| IFNA5 | TRIM21 | 0.976 | |
| IFNA6 | IFNA4 | 0.97 | |
| IFNA6 | IFNA14 | 0.969 | |
| ISG15 | UBR3 | 0.966 | 0.098 |
| IFNA17 | IFNA1 | 0.963 | |
| IFNA14 | IFNA4 | 0.953 | |
| ISG15 | IFNA8 | 0.942 | |
| TRIM21 | IFNA16 | 0.941 | |
| IFNA16 | UBR3 | 0.925 | |
| IFNA5 | IFNA1 | 0.917 | |
| TRIM21 | IFNA4 | 0.903 | |
| IFNA6 | TRIM21 | 0.879 | |
| IFNA14 | IFNA16 | 0.868 | |
| IFNA2 | TRIM21 | 0.868 | |
| UBR3 | KDF1 | 0.801 | |
| ISG15 | TRIM21 | 0.766 | 0.08 |
| TRIM21 | IFNA1 | 0.683 | |
| IFNA1 | IFNA16 | 0.675 | |
| TRIM21 | IFNA8 | 0.628 | |
| IFNA6 | UBR3 | 0.612 | |
| IFNA7 | TRIM21 | 0.536 | |
| IFNA7 | IFNA8 | 0.502 | |
| IFNA2 | IFNA7 | 0.502 | |
| IFNA2 | IFNA8 | 0.502 | |
| IFNA8 | IFNA1 | 0.473 | |
| TRIM21 | UBR3 | 0.343 | 0.07 |
| IFNA2 | IFNA1 | 0.333 | |
| IFNA6 | IFNA16 | 0.333 | |
| IFNA4 | IFNA16 | 0.333 | |
| IFNA7 | IFNA1 | 0.318 | |
| IFNA17 | IFNA4 | 0.3 | |
| IFNA14 | IFNA17 | 0.281 | |
| IFNA6 | IFNA17 | 0.281 | |
| ISG15 | IFNA17 | 0.27 | |
| IFNA1 | UBR3 | 0.239 | |
| IFNA2 | UBR3 | 0.226 | |
| IFNA14 | UBR3 | 0.173 | |
| IFNA17 | IFNA16 | 0.15 | |
| TRIM21 | IFNA17 | 0.133 | |
| IFNA4 | UBR3 | 0.13 | |
| IFNA17 | UBR3 | 0.056 | |
| UBA7 | TRIM21 | 0.002 | 0.16 |
Related Complexes